AstraZeneca
AZN
#44
Rank
HK$2.476 T
Marketcap
HK$1,597
Share price
-0.47%
Change (1 day)
60.91%
Change (1 year)

EPS for AstraZeneca (AZN)

EPS in 2025 (TTM): HK$46.23

According to AstraZeneca's latest financial reports the company's current EPS (TTM) is HK$46.43. In 2024 the company made an earnings per share (EPS) of HK$35.55 an increase over its 2023 EPS that were of HK$30.07.

EPS history for AstraZeneca from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)HK$46.2330.05%
2024HK$35.5518.23%
2023HK$30.0781.13%
2022HK$16.60631.03%
2021HK$2.27-88.11%
2020HK$19.10136.89%
2019HK$8.06-39.41%
2018HK$13.31-28.27%
2017HK$18.56-14.37%
2016HK$21.6724.11%
2015HK$17.46127.55%
2014HK$7.67-51.96%
2013HK$15.97-58.95%
2012HK$38.91-32.2%
2011HK$57.39

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$87.21 87.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$56.37 21.42%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$10.65-77.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$29.36-36.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$180.27 288.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$16.17-65.17%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
HK$69.14 48.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$57.24 23.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$27.09-41.65%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$29.50-36.46%๐Ÿ‡ฌ๐Ÿ‡ง UK